Emr Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-06-2024
- Paid Up Capital ₹ 1.00 M
as on 20-06-2024
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 8.12%
(FY 2022)
- Profit 26.42%
(FY 2022)
- Ebitda 9.44%
(FY 2022)
- Net Worth -0.28%
(FY 2022)
- Total Assets 4.50%
(FY 2022)
About Emr Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Mohan Enaganuri and Rebala Rupakala serve as directors at the Company.
- CIN/LLPIN
U24304AP2016PTC104301
- Company No.
104301
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2016
- Date of AGM
04 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Nellore, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Emr Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Enaganuri  | Director | 20-Oct-2016 | Current |
| Rebala Rupakala | Director | 20-Oct-2016 | Current |
Financial Performance of Emr Laboratories.
Emr Laboratories Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.12% increase. The company also saw a substantial improvement in profitability, with a 26.42% increase in profit. The company's net worth dipped by a decrease of 0.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Emr Laboratories?
In 2017, Emr Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hatri Pharma Private LimitedActive 14 years 5 monthsMohan Enaganuri and Rebala Rupakala are mutual person
- Reddys Therapeutics Private LimitedActive 8 years 2 months
Mohan Enaganuri and Rebala Rupakala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Emr Laboratories?
Unlock and access historical data on people associated with Emr Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emr Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emr Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
